Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
ConclusionThe AGAMENON registry suggests that subjects with limited metastatic disease, selected on a clinical basis, can benefit from early surgeries. Prospective trials are needed to confirm these data.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Maca | Surgery